In VivoIsrael is well known for punching above its weight in biopharma, with the country’s industry bringing innovation to the sector. In Vivo has spoken to industry leaders there to understand the impact of
ScripThe end of each year brings a surge in venture capital funding announcements as biopharmaceutical companies and investors seek to close as many deals as possible before everyone takes off for the Dece